Loading...
  • weakness
  • To understand the indications for chest physiotherapy (e.g., respiratory muscle weakness and its related sequels) and the effects of chest physiotherapy program will shed light on if routine chest physiotherapy should be implanted for patients with advanced lung cancer during treatment. (clinicaltrials.gov)
  • Dyspnea
  • The purpose for the 1st phase of this study are to exam longitudinal changes and the impact of various treatments on the respiratory muscle function, and the relations with dyspnea, functional capacity, quality of life, 6- and 12-month respiratory morbidity, and survival status (control group). (clinicaltrials.gov)
  • function
  • Respiratory muscle function and the impacts of various treatments regimens have not been investigated longitudinally in patients with advanced lung cancer patients. (clinicaltrials.gov)
  • Respiratory muscle function was assessed by measurement of the maximum pressures generated during occlusions at end inspiration (Pemax) and end expiration (Pimax) and lung function by measurement of lung volume (functional residual capacity (FRC)) and respiratory system compliance (CRS) and resistance (RRS) in 18 infants with a median gestational age of 28 (range 24-36) weeks. (springer.com)
  • Laubscher B, Greenough A, Dimitriou G (1998) Comparative effects of theophylline and caffeine on respiratory function of prematurely born infants. (springer.com)
  • cough
  • Comparison of the 2 groups revealed that the intervention group had greater improvements in pulmonary function, cough capacity, and muscle activity. (go.jp)
  • skeletal
  • ICU patients undergo long periods of immobilization due to prolonged sedation and mechanical ventilation which have been shown to have detrimental effects on skeletal muscle mass within a few days after ICU admission. (redorbit.com)
  • severe
  • Research in animals has shown that diaphragmatic inactivity produces severe injury and atrophy of muscle fibers. (annals.org)
  • subjects
  • One particular study by Terry Dupler and William Amonette found that using the PowerLung for as little as 4 weeks with a study group of athlete"s showed significant changes in the respiratory capacity of the test subjects. (activeforever.com)
  • lungs
  • Results demonstrate that inhaled MWCNT, which deposit in the lungs, are transported to the parietal pleura, the respiratory musculature and the systemic organs in a singlet form and accumulate with time following exposure. (cdc.gov)
  • intervention group
  • Both groups participated in a conventional stroke rehabilitation program, while the intervention group also received respiratory muscle training for 20 to 30 minutes a day, 3 times a week, for 8 weeks. (go.jp)
  • During the study period, the intervention group received bedside respiratory muscle training twice a day for three weeks. (clinicaltrials.gov)
  • The intervention group participated in a conventional stroke rehabilitation program, which consisted of joint range of motion exercises, muscle strengthening, gait training, fine motor exercises, and activity of daily living training. (clinicaltrials.gov)
  • During the same period, the intervention group also took part in bedside respiratory muscle training twice a day for 7 days a week over a 3-week period. (clinicaltrials.gov)
  • 1999
  • PowerLung has been time tested, since its release in 1999 it has been the leader in respiratory training and with its selection of different models and series no other can compare. (activeforever.com)
  • Organs
  • Transport of inhaled MWCNT to the pleura, respiratory muscles and systemic organs. (cdc.gov)
  • Inhalation exposure studies of mice were conducted to determine if multi-walled carbon nanotubes (MWCNT) distribute to the parietal pleura, respiratory musculature and systemic organs. (cdc.gov)
  • The burden of singlet MWCNT in parietal pleura, respiratory musculature and systemic organs at 48 weeks post exposure was significantly higher than at 1 day post exposure. (cdc.gov)